IFO Istituto Regina Elena

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Lung cancer2 trials
• Sarcoma1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Bristol-Myers Squibb1 trial
• Gruppo Oncologico Italiano di Ricerca Clinica1 trial
• Istituto Oncologico Veneto IRCCS1 trial

Running trials

• Active, not recruiting

  Alectinib in Neo-adjuvant Treatment of Stage III NSCLC

  NCT05015010· Phase 2· Gruppo Oncologico Italiano di Ricerca Clinica· Source

Closed trials

• Terminated

  Low Dose Continuous Cyclophosphamide vs Standard Doxorubicin in Advanced Sarcoma Elderly Patients

  NCT04656262· Phase 3· Istituto Oncologico Veneto IRCCS· Source

• Completed

  An Investigational Immuno-therapy Trial of Nivolumab, or Nivolumab Plus Ipilimumab, or Nivolumab Plus Platinum-doublet Chemotherapy, Compared to Platinum Doublet Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer (NSCLC)

  NCT02477826· Phase 3· Bristol-Myers Squibb· Source